Towards Healthcare Research & Consulting

U.S. Endobronchial Ultrasound Biopsy Companies and Competitive Landscape

Date : 08 June 2026

Top Companies and Their Offerings in the Market

U.S. Endobronchial Ultrasound Biopsy Market Companies are Olympus Corporation, Medtronic plc, Fujifilm Holdings Corporation, Medi-Globe GmbH, PENTAX Medical, Micro-Tech Endoscopy, Boston Scientific Corporation, Verna Medical Technologies, Cook Medical, Medtronic plc

Tier 1
Company Name Headquarters Country Why Relevant to This Market Key Products/Services Related to Keyword
Olympus Corporation Tokyo, Tokyo Prefecture Japan Global leader in bronchoscopy and EBUS systems with dominant U.S. installed base BF-UC series EBUS bronchoscopes, EU-ME3 ultrasound processor, EBUS-TBNA platform
FUJIFILM Holdings Corporation Tokyo, Tokyo Prefecture Japan Major EBUS imaging and bronchoscopy technology provider ARIETTA ultrasound systems, EBUS-compatible bronchoscopes
PENTAX Medical (HOYA Group) Tokyo, Tokyo Prefecture Japan Strong pulmonary endoscopy and EBUS platform provider Linear EBUS bronchoscopes, ultrasound endoscopy systems
Boston Scientific Corporation Marlborough, Massachusetts USA Major supplier of EBUS biopsy needles and pulmonary intervention tools EBUS-TBNA needles, pulmonary biopsy accessories
Cook Medical Bloomington, Indiana USA Leading biopsy needle and interventional pulmonology supplier EchoTip EBUS needles, pulmonary biopsy devices
Tier 2
Company Name Headquarters Country Why Relevant to This Market Key Products/Services Related to Keyword
CONMED Corporation Largo, Florida USA Active supplier of bronchoscopy consumables and accessories Bronchoscopic biopsy consumables and procedural accessories
Medtronic plc Dublin Ireland Strong presence in advanced bronchoscopy and pulmonary diagnostics Pulmonary navigation systems, biopsy accessories
KARL STORZ SE & Co. KG Tuttlingen, Baden-Württemberg Germany Significant bronchoscopy equipment provider Bronchoscopy systems and visualization platforms
Siemens Healthineers AG Erlangen, Bavaria Germany Imaging infrastructure supporting EBUS-guided diagnostics CT imaging and pulmonary diagnostic workflow solutions
GE HealthCare Technologies Inc. Chicago, Illinois USA Imaging systems widely integrated into lung cancer diagnostic pathways Advanced thoracic imaging systems
Tier 3
Company Name Headquarters Country Why Relevant to This Market Key Products/Services Related to Keyword
Praxis Medical St. Paul, Minnesota USA Developer of innovative motorized EBUS biopsy technologies EndoCore EBUS-TBNA biopsy device
Medi-Globe Technologies GmbH Achenmühle, Bavaria Germany Specialized biopsy and endoscopy device manufacturer EBUS biopsy needles and pulmonary accessories
ACE Medical Devices Pvt. Ltd. New Delhi, Delhi India Specialized pulmonary and biopsy consumables provider EBUS-TBNA needles and accessories
Philips Healthcare Amsterdam, North Holland Netherlands Growing influence through pulmonary imaging integration Advanced pulmonary imaging and intervention guidance
Intuitive Surgical, Inc. Sunnyvale, California USA Robotic bronchoscopy expansion increasingly complements EBUS procedures Ion robotic-assisted bronchoscopy platform

What are the Recent Developments in the Market?

  • In May 2026, the EB-710US Ultrasound Bronchoscope, which is an endobronchial ultrasound (EBUS) solution, was launched by Fujifilm Healthcare Americas Corp. The product will offer improved imaging performance and streamline workflow for pulmonologists and healthcare systems.
  • In July 2025, the next-generation EU-ME3 Ultrasound Processor was launched in the U.S. by the Olympus Corporation of the Americas, which is a global MedTech company. The product combines endobronchial and endoscopic ultrasound (EUS/EBUS) on a single workstation to offer improved functionality and image quality.

Market Value Chain Analysis

R&D

  • The R&D of the U.S. endobronchial ultrasound biopsy focuses on the development of slimmer, high-angle bronchoscopes, high-yielding histological core needles, and AI-based diagnostics.
  • Key players: Olympus Corporation, Boston Scientific Corporation, and Cook Medical.

Clinical Trials and Regulatory Approvals

  • The diagnostics yield, procedural safety, device maneuverability, and tissue adequacy are evaluated in the clinical trials and regulatory approvals of the U.S. endobronchial ultrasound biopsy.
  • Key players: Olympus Corporation, Boston Scientific Corporation, and Cook Medical.

Packaging and Serialization

  • The packaging and sterilization of the U.S. endobronchial ultrasound biopsy involves the use of sterile, puncture-resistant Tyvek pouches complying with FDA Unique Device Identification (UDI) regulations and serialized 2D data matrix barcodes.
  • Key players: Olympus Corporation, Boston Scientific Corporation, and Cook Medical.

Distribution to Hospitals, Pharmacies

  • The large-scale national health logistics distributor and manufacturing giants are responsible for the distribution of the endobronchial ultrasound biopsy across the U.S. hospitals and pharmacies.
  • Key players: Cardinal Health, Olympus Corporation, Boston Scientific Corporation.

Patient Support and Services

  • Patient education programs, insurance navigation toolkits, and copay support services are provided in the patient support and services of the U.S. endobronchial ultrasound biopsy.
  • Key players: Olympus Corporation, Boston Scientific Corporation, and Cook Medical.

Market Ecosystem Analysis

Ecosystem Segment Representative Participants Role in Market
Technology Providers Olympus Corporation, FUJIFILM Holdings Corporation, HOYA Corporation EBUS imaging platforms, ultrasound processors, bronchoscopy technologies
Product Manufacturers Olympus, FUJIFILM, PENTAX Medical, Boston Scientific, Cook Medical EBUS scopes, biopsy needles, processors, accessories
Service Providers Hospital systems, pulmonary diagnostic centers, cancer centers Clinical EBUS procedures and patient management
Platform Providers Olympus, FUJIFILM, PENTAX Medical Integrated EBUS imaging ecosystems
CROs/CDMOs Limited relevance Device clinical studies and validation support
Software Vendors Olympus, FUJIFILM, robotic bronchoscopy vendors Imaging enhancement and procedural workflow software
Research Institutions Mayo Clinic, Cleveland Clinic, MD Anderson Cancer Center Clinical research and procedural innovation
End-User Industries Hospitals, Cancer Centers, Pulmonary Clinics, Academic Centers Utilize EBUS systems for diagnosis and staging

Market Growth

The U.S. endobronchial ultrasound biopsy market size was estimated at USD 412.8 million in 2025 and is predicted to increase from USD 449.54 million in 2026 to approximately USD 968.32 million by 2035, expanding at a CAGR of 8.9% from 2026 to 2035.

U.S. Endobronchial Ultrasound Biopsy Market Size is USD 449.54 Million in 2026.